Searched for: author%3A%22van+Wietmarschen%2C+H.A.%22
(1 - 9 of 9)
document
Brink, S.M. (author), Wortelboer, H. (author), Emmelot, C.H. (author), Visscher, T.L.S. (author), van Wietmarschen, H.A. (author)
Current obesity management strategies are failing to achieve sustainable and favorable long-term results. We propose a more personalized, dynamic, and systemic perspective on the interactions of key determinants and coaching advice on obesity. The aim of this study was to use a systems view on overweight, complexity science, and a...
article 2022
document
Fu, J. (author), van Wietmarschen, H.A. (author), van der Kooij, A. (author), Cuppen, B.V.J. (author), Schroën, Y. (author), Marijnissen, A.K. (author), Meulman, J.J. (author), Lafeber, F.P.J.G. (author), van der Greef, J. (author)
Introduction: Biological therapies have greatly improved the treatment efficacy in rheumatoid arthritis (RA). However, in clinical practice a significant proportion of patients experience an inadequate response to treatment. The aim of this study is to classify responding and non-responding rheumatoid arthritis patients treated with biological...
article 2018
document
Schoeman, J.C. (author), Harms, A.C. (author), van Wietmarschen, H.A. (author), Vreeken, R.J. (author), Berger, R. (author), Cuppen, B.V.J. (author), Lafeber, F.P.J.G. (author), van der Greef, J. (author), Hankemeier, T. (author)
Oxidised lipids, covering enzymatic and auto-oxidation-synthesised mediators, are important signalling metabolites in inflammation while also providing a readout for oxidative stress, both of which are prominent physiological processes in a plethora of diseases. Excretion of these metabolites via urine is enhanced through the phase-II...
article 2016
document
Cuppen, B.V.J. (author), Fu, J. (author), van Wietmarschen, H.A. (author), Harms, A.C. (author), Koval, S. (author), Marijnissen, A.C.A. (author), Peeters, J.J.W. (author), Bijlsma, J.W.J. (author), Tekstra, J. (author), van Laar, J.M. (author), Hankemeier, T. (author), Lafeber, F.P.J.G. (author), van der Greef, J. (author)
In clinical practice, approximately one-Third of patients with rheumatoid arthritis(RA) respond insufficiently to TNF-alpha inhibitors (TNFis). The aim of the study was to explore the use of a metabolomics to identify predictors for the outcome of TNFi therapy, and study the metabolomic fingerprint in active RA irrespective of patients' response...
article 2016
document
van Wijk, R. (author), van Wijk, E.P.A. (author), van Wietmarschen, H.A. (author), van der Greef, J. (author)
For decades, the relationship between ultra-weak photon emission (UPE) and the health state of the body is being studied. With the advent of systems biology, attention shifted from the association between UPE and reactive oxygen species towards UPE as a reflection of changed metabolic networks. Essential for this shift in thinking is the...
article 2014
document
Schroën, Y. (author), van Wietmarschen, H.A. (author), Wang, M. (author), van Wijk, E.P. (author), Hankemeier, T. (author), Xu, G. (author), van der Greef, J. (author)
article 2014
document
van Wietmarschen, H.A. (author), der Greef, J.V. (author), Schroën, Y. (author), Wang, M. (author)
Ethnopharmacological relevance Rehmannia Six Formula (R6, Chinese name is Liu Wei Di Huang Wan) is one of the most important classic Chinese medicine formula used to treat metabolic disorders related to aging. It was first reported in the Chinese medicine book titled 'Xiao Er Yao Zheng Zhi Jue by Qian Yi' (Chinese Song dynasty: 1035-1117). In...
article 2013
document
van Wietmarschen, H.A. (author), Dai, W. (author), van der Kooij, A.J. (author), Reijmers, T.H. (author), Schroën, Y. (author), Wang, M. (author), Xu, Z. (author), Wang, X. (author), Kong, H. (author), Xu, G. (author), Hankemeier, T. (author), Meulman, J.J. (author), van der Greef, J. (author)
Objective: The aim is to characterize subgroups or phenotypes of rheumatoid arthritis (RA) patients using a systems biology approach. The discovery of subtypes of rheumatoid arthritis patients is an essential research area for the improvement of response to therapy and the development of personalized medicine strategies. Methods: In this study,...
article 2012
document
van Wietmarschen, H.A. (author), Reijmers, T.H. (author), van der Kooij, A.J. (author), Schroën, J. (author), Wei, H. (author), Hankemeier, T. (author), Meulman, J.J. (author), van der Greef, J. (author)
Background: The future of personalized medicine depends on advanced diagnostic tools to characterize responders and non-responders to treatment. Systems diagnosis is a new approach which aims to capture a large amount of symptom information from patients to characterize relevant sub-groups. Methodology: 49 patients with a rheumatic disease were...
article 2011
Searched for: author%3A%22van+Wietmarschen%2C+H.A.%22
(1 - 9 of 9)